Co-Authors
This is a "connection" page, showing publications co-authored by Isik Johansen and Ole Søgaard.
Connection Strength
0.297
-
Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial. EClinicalMedicine. 2021 May; 35:100849.
Score: 0.235
-
Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study. Clin Infect Dis. 2021 12 06; 73(11):2031-2036.
Score: 0.061